Skip to main content

Advertisement

Fig. 1 | BMC Complementary and Alternative Medicine

Fig. 1

From: Effect of tt-farnesol and myricetin on in vitro biofilm formed by Streptococcus mutans and Candida albicans

Fig. 1

Treatment regimens used for topical application. a Depicts the regimen one used to accesses the effect on pre-formed biofilms (treatments application starts at 19 h of biofilm development). b Depicts the regimen two used to evaluate the effect on biofilm assembly and accumulation (treatments application on saliva-coated hydroxyapatite discs before microbial inoculation)

Back to article page